StarGate Capital Investment Group
Stargate Capital Management Limited is a private equity and venture capital firm based in London, United Kingdom, with a focus on investments in emerging enterprise market segments. Established in 2004 as a subsidiary of Stargate Capital Investment Group Limited, the firm addresses a significant funding gap faced by entrepreneurs, especially women, who struggle to secure investments ranging from £500,000 to £5 million to scale their businesses. Stargate Capital Management seeks to bridge this gap by investing in carefully selected growth companies. Beyond providing financial capital, the firm also offers access to influential networks and resources, enhancing the growth potential of the businesses in which it invests.
Femeda Ltd. is a UK-based company specializing in the development and manufacturing of medical devices aimed at treating female urinary incontinence. Established in 2002 and located in Cramlington, Femeda focuses on creating innovative solutions to address bladder leakage issues caused by weak pelvic floor muscles. Its flagship product, Pelviva, employs electro stimulation technology to proactively treat incontinence, enhancing the quality of life for women affected by this condition. The company's research and development efforts are driven by consumer needs, ensuring that Pelviva is designed to provide effective support. With backing from a dedicated group of investors, Femeda has successfully advanced its R&D program, leading to the product's anticipated launch.
Femeda Ltd. is a UK-based company specializing in the development and manufacturing of medical devices aimed at treating female urinary incontinence. Established in 2002 and located in Cramlington, Femeda focuses on creating innovative solutions to address bladder leakage issues caused by weak pelvic floor muscles. Its flagship product, Pelviva, employs electro stimulation technology to proactively treat incontinence, enhancing the quality of life for women affected by this condition. The company's research and development efforts are driven by consumer needs, ensuring that Pelviva is designed to provide effective support. With backing from a dedicated group of investors, Femeda has successfully advanced its R&D program, leading to the product's anticipated launch.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.